I attended the launch event of the Imperial College London Antimicrobial Research Collaborative this week. The Antimicrobial Research Collaborative (ARC@Imperial) consolidates world leading, multidisciplinary research across Imperial College London to address the urgent global threat of antimicrobial resistance. I had the opportunity to meet Dr Martin Cole. Dr Cole led the team that developed the antibiotic Augmentin (also known by its generic name of Co-Amoxiclav) by adding Clavulanate Potassium to Amoxicillin.
Dr Martin Cole who led the team that developed the antibiotic Augmentin
Sir Richard Sykes, Chairman of the Imperial College Healthcare NHS Trust and Professor Alice Gast, President of Imperial College London